REG
MAR
Eevia Health Plc Interim Report Q3 - 2023
Significant events during the third quarter of 2023:
Net sales1 decreased by 20% from KEUR 1 148 in Q3-22 to KEUR 917 in Q3-23. Compared to the second quarter this year, Net sale...
Eevia Health Plc appoints Breko as distributor in DACH countries
Eevia Health Plc, ("Eevia" or "The Company") has appointed Breko GmbH in Bremen, Germany as its new distributor in the territory of Germany (D), Austria (A), and Switzerland (CH)...
Eevia Health Plc gained significant new sales opportunities from key US tradeshow
Eevia Health Plc ("Eevia" or "The Company") concluded a successful tradeshow exhibition at the Supply Side West in Las Vegas, USA. The proceeds from the tradeshow are over 30 new...
Eevia Health Plc exhibiting and launching a new sku at a key tradeshow - Supply Side West in Las Vegas
Eevia Health Plc ("Eevia" or "The Company") is promoting its organic health ingredients by exhibiting at Supply Side West, a premier nutraceutical tradeshow in Las Vegas, USA bet...
Eevia Health Plc receives a 1 mSEK/94 kEUR sales order for a Bilberry extract product
Eevia Health Plc, ("Eevia" or "The Company"), has received a 94 kEUR sales order from a European nutraceutical brand owner.
Eevia Health Plc receives A 439 Ksek (38 KEUR) sales order for Feno-Sambucus™ 7 Organic
Eevia Health ("Eevia" or "The Company") received a 439 kSEK / 38 kEUR sales order for the elderberry extract Feno-Sambucus™ 7 ORGANIC from a distributor in the US.
Eevia Health Plc received a 295 kSEK / 25 kEUR sales order for a Bilberry juice powder product
Eevia Health Plc's ("Eevia" or "The Company") has received a 25 kEUR (295 kSEK) sales order from a Finnish customer for organically certified Bilberry Juice powder.
REG
Eevia Health Plc received a 718 kSEK / 62 kEUR sales order for a Bilberry extract product
Eevia Health Plc's ("Eevia" or "The Company") has received a 62 kEUR (718 kSEK) repeat sales order from a French distributor customer for Feno-Myrtillus 36 organic, an organicall...
Eevia Health Plc received a 168 kSEK / 15 kEUR order for a rapeseed extract.
Eevia Health Plc, ("Eevia" or "The Company"), has received a sales order from a Finnish food company for a custom made rapeseed extract for the value of 15 kEUR (168 kSEK).
Eevia Health Plc receiveS A 757 Ksek (66 KEUR) sales order for Feno-Sambucus™ 7 Organic
Eevia Health ("Eevia" or "The Company") received a 757 kSEK / 66 kEUR sales order for the elderberry extract Feno-Sambucus™ 7 ORGANIC from a distributor in the US.
Eevia Health Plc receives a 171 kSEK / 15 kEUR sales order for a Chaga extract
Eevia Health Plc ("Eevia" or "The Company") has received an 11 KEUR sales order for Feno-Chaga® Organic from a nutraceutical brand in the USA.
Eevia Health Plc received a 541 kSEK / 47 kEUR sales order for a Bilberry extract product
Eevia Health Plc's ("Eevia" or "The Company") has received a 47 kEUR (541 kSEK) repeat sales order from a German customer for Feno-Myrtillus 36 organic, an organically certified...
Eevia Health Plc releases a new scientific article on the BioMAP study for the data and results relating to Feno-Sambucus® Organic, Eevia's organic Elderberry extract product line
Eevia Health Plc ("Eevia" or "The Company") has released a scientific article on the results of the recently completed BioMAP study that was done with Eurofins. The new article o...
Eevia Health Plc received a 473 KSEK / 41 KEUR sales order for a Bilberry extract product
Eevia Health Plc's ("Eevia" or "The Company") has received a 41 kEUR sales order from a European customer for Feno-Myrtillus 36 organic, an organically certified bilberry extract.
Eevia Health Plc releases a new white paper on Feno-Myrtillus® Organic, Eevia's organic bilberry extract product line
Eevia Health Plc ("Eevia" or "The Company") has released a white paper featuring the Feno-Myrtillus® Organic, an organically certified and trade-name protected product line of bi...
Eevia Health Plc received a kEUR 495 working capital loan from Nordea
Eevia Health Plc, ("Eevia" or "The Company") has received a working capital loan of kEUR 495 from the Start-Up and Growth division of Nordea Finland with a 70% guarantee from Fin...
Eevia Health Plc confirms a top-ranking performance of key products in a broad scientific study by Eurofins, comparing against competitor alternatives
Eevia Health Plc, ("Eevia" or "The Company") has undertaken a broad in vitro study in cooperation with Eurofins to benchmark Eevia's extracts against the presumably strongest com...
Eevia Health Plc receives a 130 KSEK / 11 KEUR sales order for a Chaga extract
Eevia Health Plc ("Eevia" or "The Company") has received an 11 KEUR sales order for Feno-Chaga® Organic from a health-food customer in Finland.
Om Eevia Health
Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.
Webbplats
eeviahealth.com/investors
Handelsinformation
Kurs ()
Förändring ()
